Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protection against Reinfection with the Omicron BA.2.75 Subvariant
Hiam Chemaitelly, Patrick Tang, Peter Coyle, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 7, pp. 665-667
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 7, pp. 816-827
Open Access | Times Cited: 70
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Jia Wei, Nicole Stoesser, Philippa C. Matthews, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature (2025)
Open Access | Times Cited: 2
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
American Journal of Epidemiology (2023) Vol. 193, Iss. 6, pp. 883-897
Open Access | Times Cited: 25
All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic
Asma Ali Al-Nuaimi, Hiam Chemaitelly, Sandy Semaan, et al.
BMJ Global Health (2023) Vol. 8, Iss. 5, pp. e012291-e012291
Open Access | Times Cited: 23
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant
Hiam Chemaitelly, Peter Coyle, Mohamed Ali Ben Hadj Kacem, et al.
Journal of Travel Medicine (2024) Vol. 31, Iss. 4
Open Access | Times Cited: 11
A mini review of reinfection with the SARS‐CoV‐2 Omicron variant
Hongwei Shen, Dingqiang Chen, Chenglin Li, et al.
Health Science Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 7
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 7
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
Suelen H. Qassim, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EClinicalMedicine (2023) Vol. 62, pp. 102102-102102
Open Access | Times Cited: 13
The Omicron Variant Reinfection Risk among Individuals with a Previous SARS-CoV-2 Infection within One Year in Shanghai, China: A Cross-Sectional Study
Chuchu Ye, Ge Zhang, Anran Zhang, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1146-1146
Open Access | Times Cited: 12
How quickly does COVID immunity fade? What scientists know
Cassandra Willyard
Nature (2023)
Closed Access | Times Cited: 10
Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave – a nested case-control study among vaccinated adults in Sweden
Fredrik Kahn, Carl Bonander, Mahnaz Moghaddassi, et al.
IJID Regions (2024) Vol. 10, pp. 235-239
Open Access | Times Cited: 3
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
History of primary-series and booster vaccination and protection against Omicron reinfection
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 9
COVID-19 primary series and booster vaccination and potential for immune imprinting
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Effect and mechanism of quercetin or quercetin‐containing formulas against COVID‐19: From bench to bedside
Jhong Yuan Chen, Tsung Rung Huang, Shih Yun Hsu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2597-2618
Closed Access | Times Cited: 2
Integrated analyses of the transmission history of SARS-CoV-2 and its association with molecular evolution of the virus underlining the pandemic outbreaks in Italy, 2019-2023
Eleonora Cella, Vagner Fonseca, Francesco Branda, et al.
International Journal of Infectious Diseases (2024) Vol. 149, pp. 107262-107262
Closed Access | Times Cited: 2
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Jeremy Samuel Faust, et al.
BMJ Public Health (2023) Vol. 1, Iss. 1, pp. e000479-e000479
Open Access | Times Cited: 6
A turning point in COVID-19 severity and fatality during the pandemic: A national cohort study in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Jeremy Samuel Faust, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey
Juan P. Aguilar Ticona, Meng Xiao, Dan Li, et al.
International Journal of Infectious Diseases (2023) Vol. 139, pp. 159-167
Open Access | Times Cited: 5
Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta infections
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: An observational study
Suelen H. Qassim, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study
Mai Mahmoud, Houssein H. Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 11
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top